scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1003836243 |
P356 | DOI | 10.1007/S11920-012-0279-6 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s11920-012-0279-6 |
P932 | PMC publication ID | 3752388 |
P698 | PubMed publication ID | 22562412 |
P50 | author | Yvette I Sheline | Q79466707 |
P2093 | author name string | Brianne M Disabato | |
P2860 | cites work | Anterior cingulate cortical volumes and treatment remission of geriatric depression | Q24642093 |
Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey | Q28168583 | ||
Improvement of cognitive functioning in mood disorder patients with depressive symptomatic recovery during treatment: an exploratory analysis | Q28262333 | ||
Hippocampus shape analysis and late-life depression | Q33324413 | ||
Diffuse microstructural abnormalities of normal-appearing white matter in late life depression: a diffusion tensor imaging study | Q33431542 | ||
Psychomotor slowing and subcortical-type dysfunction in depression | Q33629519 | ||
Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial | Q33726069 | ||
Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study | Q33844090 | ||
Amygdalae morphometry in late-life depression | Q33857645 | ||
Gray matter changes in late life depression--a structural MRI analysis | Q33857687 | ||
Cytokines and the brain: implications for clinical psychiatry | Q33900651 | ||
Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors | Q33988553 | ||
MRI signal hyperintensities and treatment remission of geriatric depression | Q34160970 | ||
Three-dimensional surface mapping of the caudate nucleus in late-life depression | Q34267093 | ||
The relationship of depression and stressors to immunological assays: a meta-analytic review | Q34375707 | ||
How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis | Q34390776 | ||
Progression of white matter hyperintensities in elderly individuals over 3 years | Q34602174 | ||
Microstructural white matter abnormalities and remission of geriatric depression | Q34732676 | ||
Depressive symptoms, brain volumes and subclinical cerebrovascular disease in postmenopausal women: the Women's Health Initiative MRI Study | Q35028141 | ||
Amygdala volume in late-life depression: relationship with age of onset | Q35188783 | ||
Neuroanatomical characteristics of geriatric apathy and depression: a magnetic resonance imaging study | Q35401616 | ||
Inflammatory mediators in the elderly | Q35766426 | ||
Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. | Q35994979 | ||
Hippocampal volume and subcortical white matter lesions in late life depression: comparison of early and late onset depression | Q36143834 | ||
Temporal lobe abnormalities in dementia and depression: a study using high resolution single photon emission tomography and magnetic resonance imaging | Q36317321 | ||
Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations | Q36482713 | ||
Depression and cognition in older adults | Q37087209 | ||
Neurocognitive correlates of response to treatment in late-life depression | Q37293670 | ||
Depressive symptoms and brain volumes in older adults: a longitudinal magnetic resonance imaging study. | Q37320815 | ||
Treatment response in late-onset depression: relationship to neuropsychological, neuroradiological and vascular risk factors. | Q51943280 | ||
Longitudinal association of initiation/perseveration and severity of geriatric depression. | Q51944004 | ||
Subcortical white matter lesions and functional impairment in geriatric depression. | Q51960277 | ||
Persistence of neuropsychologic deficits in the remitted state of late-life depression. | Q51982843 | ||
Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. | Q51995510 | ||
Prognostic value of frontal functional neuroimaging in late-onset severe major depression. | Q53627016 | ||
Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression | Q57244759 | ||
Inflammatory Proteins and Depression in the Elderly | Q57338024 | ||
Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia∗∗The opinions and assertions expressed herein are those of the authors and are not to be construed as reflect | Q57392445 | ||
Soluble cell adhesion molecules in late-life depression | Q57813708 | ||
Increase in Interleukin-1β in Late-Life Depression | Q57813826 | ||
Hippocampal volume change in depression: Late- and early-onset illness compared | Q57813860 | ||
Elevation in Late-Life Depression of Intercellular Adhesion Molecule-1 Expression in the Dorsolateral Prefrontal Cortex | Q57814052 | ||
The Nature and Determinants of Neuropsychological Functioning in Late-LifeDepression | Q58479272 | ||
Hippocampal volume in geriatric depression | Q74227453 | ||
Inflammatory markers in late-life depression: results from a population-based study | Q80837482 | ||
MRI High-Intensity Signals in Late-Life Depression and Alzheimer's Disease: A Comparison of Subjects Without Major Vascular Risk Factors | Q38771335 | ||
Association of interleukin-6 and other biologic variables with depression in older people living in the community | Q39484897 | ||
Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study | Q39956247 | ||
Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed | Q40357986 | ||
C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984-1998. | Q40393807 | ||
Greater MRI lesion volumes in elderly depressed subjects than in control subjects | Q40417825 | ||
White Matter Hyperintensity Progression and Late-Life Depression Outcomes | Q40550525 | ||
Cytokines and the hepatic acute phase response | Q41474260 | ||
'Vascular depression' hypothesis | Q41616775 | ||
Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine | Q42167218 | ||
Dual-task performance in depressed geriatric patients. | Q43641332 | ||
The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients | Q43854243 | ||
Neuropsychological functioning and MRI signal hyperintensities in geriatric depression | Q43966382 | ||
Frontal white matter microstructure and treatment response of late-life depression: a preliminary study | Q44201503 | ||
Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy | Q44239552 | ||
Cognitive functioning and the natural course of depressive symptoms in late life | Q44490877 | ||
Social and psychosocial influences on inflammatory markers and vascular function in civil servants (the Whitehall II study). | Q44616016 | ||
Prefrontal brain morphology and executive function in healthy and depressed elderly | Q44671560 | ||
Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study | Q44811011 | ||
Exploring the pattern and neural correlates of neuropsychological impairment in late-life depression. | Q44833286 | ||
Changes in cognitive functioning following treatment of late-life depression | Q44944122 | ||
Neuroanatomical and neuropsychological features of elderly euthymic depressed patients with early- and late-onset | Q45033558 | ||
A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. | Q45130108 | ||
Executive dysfunction and the course of geriatric depression | Q46600037 | ||
Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study | Q47657388 | ||
Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex | Q48102665 | ||
Prefrontal dysfunction and treatment response in geriatric depression | Q48144033 | ||
MRI Lesion Severity and Mortality in Geriatric Depression | Q48148807 | ||
Subcortical lesion severity and orbitofrontal cortex volume in geriatric depression | Q48213622 | ||
Vascular health and longitudinal changes in brain and cognition in middle-aged and older adults | Q48220739 | ||
Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression | Q48243726 | ||
Event-related potentials in an emotional go/no-go task and remission of geriatric depression | Q48266673 | ||
Six-month outcomes for MRI-related vascular depression. | Q48317641 | ||
Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. | Q48363247 | ||
Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. | Q48364631 | ||
White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: the LADIS study. | Q48413153 | ||
Virchow-Robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression. | Q48443459 | ||
White matter hyperintensity signals in psychiatric and nonpsychiatric subjects | Q48486109 | ||
Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. | Q48523953 | ||
Cell adhesion molecule expression in the dorsolateral prefrontal cortex and anterior cingulate cortex in major depression in the elderly. | Q48526290 | ||
Hippocampal volume and antidepressant response in geriatric depression. | Q48552840 | ||
Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain. | Q48642151 | ||
MRI-defined vascular depression. | Q48753769 | ||
MRI signal hyperintensities and failure to remit following antidepressant treatment. | Q48820688 | ||
Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. | Q48923423 | ||
MRI signal hyperintensities in geriatric depression. | Q48937476 | ||
Cognitive impairment in late-onset depression. Limited to a decrement in information processing resources? | Q49081612 | ||
Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. | Q49143781 | ||
Signal hyperintensities on brain magnetic resonance imaging in elderly depressed patients. | Q51000645 | ||
The pattern and course of cognitive impairment in late-life depression. | Q51865017 | ||
Response inhibition predicts poor antidepressant treatment response in very old depressed patients. | Q51902253 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | late life depression | Q438896 |
P304 | page(s) | 273-279 | |
P577 | publication date | 2012-08-01 | |
P1433 | published in | Current Psychiatry Reports | Q25245507 |
P1476 | title | Biological basis of late life depression | |
P478 | volume | 14 |
Q48073679 | Altered serum fatty acid composition in geriatric depression |
Q97437006 | Association of Markers of Microvascular Dysfunction With Prevalent and Incident Depressive Symptoms: The Maastricht Study |
Q30724976 | Brain network dysfunction in late-life depression: a literature review |
Q50531989 | Depressive Symptom Dimensions and Their Association with Hippocampal and Entorhinal Cortex Volumes in Community Dwelling Older Adults. |
Q37699075 | Depressive symptoms, symptom dimensions, and white matter lesion volume in older adults: a longitudinal study |
Q36915385 | Dimensions of depressive symptoms and cingulate volumes in older adults |
Q38067355 | Duloxetine: a review of its use in the management of major depressive disorder in older adults |
Q30920004 | Increased cerebral water content in hemodialysis patients |
Q47287511 | Late-Life Depressive Symptoms as Partial Mediators in the Associations between Subclinical Cardiovascular Disease with Onset of Mild Cognitive Impairment and Dementia |
Q36383001 | Machine learning approaches for integrating clinical and imaging features in late-life depression classification and response prediction |
Q35157110 | Multimodal brain connectivity analysis in unmedicated late-life depression. |
Q44747074 | Organic bases of late-life depression: a critical update |
Q28079484 | Peripheral Inflammatory Parameters in Late-Life Depression: A Systematic Review |
Q38103882 | Pharmacogenetic considerations for late life depression therapy |
Q37308873 | Structural brain changes as biomarkers and outcome predictors in patients with late-life depression: a cross-sectional and prospective study. |
Q42374732 | Vascular depression consensus report - a critical update. |
Q48002709 | Vertex-wise examination of depressive symptom dimensions and brain volumes in older adults |
Search more.